risperidone has been researched along with oxadiazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jardemark, K; Malmerfelt, A; Marcus, MM; Shahid, M; Svensson, TH | 1 |
Cross, A; Doherty, JJ; Gertsik, L; Litman, RE; Raines, S; Smith, MA; Zukin, SR | 1 |
1 trial(s) available for risperidone and oxadiazoles
Article | Year |
---|---|
AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
Topics: Adolescent; Adult; Allosteric Regulation; Antipsychotic Agents; Double-Blind Method; Female; Humans; Indoles; Male; Middle Aged; Oxadiazoles; Psychiatric Status Rating Scales; Receptors, Metabotropic Glutamate; Risperidone; Schizophrenia; Treatment Outcome; Young Adult | 2016 |
1 other study(ies) available for risperidone and oxadiazoles
Article | Year |
---|---|
Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Drug Synergism; Glutamic Acid; Glycine Plasma Membrane Transport Proteins; Haloperidol; Male; Membrane Potentials; Olanzapine; Oxadiazoles; Piperidines; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, AMPA; Risperidone; Synaptic Transmission; Tetrahydronaphthalenes | 2012 |